Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
Sponsor: Samsung Medical Center
Summary
This prospective study enrolls patients who are diagnosed with aggressive lymphoma including Hodgkin and non-Hodgkin lymphomas. Enrolled patients will be treated according to our institution' treatment policy in clinical practice. The disease status including response to therapy and survival status will be regularly updated during the study period. Patients' serum and cell-free DNA will be collected and analyzed.
Official title: A Prospective Study for Patients With Lymphoma at the Samsung Medical Center
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2022-06-01
Completion Date
2028-12-30
Last Updated
2025-06-22
Healthy Volunteers
No
Conditions
Interventions
Immunochemotherapy
Systemic chemotherapy with curative intent
Locations (1)
Samsung Medical Center
Seoul, South Korea